Siren, L.L.C. Allovir, Inc. Transaction History
Siren, L.L.C.
- $2 Trillion
- Q3 2024
A detailed history of Siren, L.L.C. transactions in Allovir, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 6,597,167 shares of ALVR stock, worth $66.3 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
6,597,167Holding current value
$66.3 Million% of portfolio
0.27%Shares
1 transactions
Others Institutions Holding ALVR
# of Institutions
52Shares Held
42.6MCall Options Held
14.9KPut Options Held
200-
Eco R1 Capital, LLC San Francisco, CA11.3MShares$114 Million0.4% of portfolio
-
Octagon Capital Advisors LP New York, NY11.2MShares$113 Million2.19% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.28MShares$33 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$26.6 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA1.91MShares$19.2 Million0.1% of portfolio
About Allovir, Inc.
- Ticker ALVR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,063,400
- Market Cap $935M
- Description
- Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...